- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Gut microbiome tied with increased morbidity in childhood asthma
Gut microbiome features are associated with wheeze frequency in children with asthma suggesting an impact of the gut microbiome on morbidity in childhood asthma, according to a recent study published in the Journal of Allergy and Clinical Immunology.
While the microbiome has an established role in asthma development, less is known about its contribution to morbidity in children with asthma.
In this ancillary study of the Vitamin D Antenatal Asthma Reduction Trial (VDAART), we analyzed the gut microbiome and metabolome of wheeze frequency in children with asthma.
Bacterial 16s rRNA microbiome and untargeted metabolomic profiling were performed on faecal samples collected from three-year-old children with parent-reported physician-diagnosed asthma. Researchers analyzed wheeze frequency by calculating the proportion of quarterly questionnaires between ages 3 and 5 years in which parents reported the child had wheezed ("wheeze proportion"). Taxa and metabolites associated with wheeze were analyzed by identifying log-fold. In children with asthma, intestinal Veillonella abundance was associated with more frequent wheeze and with numerous faecal metabolites, suggesting significant functional potential and clinical relevance of this genus. Children with asthma who wheezed more often demonstrated a shift in their faecal metabolomic composition, including enrichment with histidine metabolites. Changes with respect to wheeze frequency and correlation/linear regression analyses, respectively.
Microbe-metabolite and microbe-microbe correlation networks were compared between subjects with high and low wheeze proportions.
Results of the study are:
Specific taxa, including the genus Veillonella and histidine pathway metabolites, were enriched in subjects with high wheeze proportion. Amongst wheeze-associated taxa, Veillonella and Oscillospiraceae UCG-005, which was inversely associated with wheeze, were correlated with the greatest number of fecal metabolites. Microbial networks were similar between subjects with low vs. high wheeze frequency.
Thus, Gut microbiome features are associated with wheeze frequency in children with asthma, suggesting an impact of the gut microbiome on morbidity in childhood asthma.
Reference:
Association of the Gut Microbiome and Metabolome with Wheeze Frequency in Childhood Asthma by Kathleen Lee-Sarwar, et al. published in the Journal of Allergy and Clinical Immunology.
https://www.jacionline.org/article/S0091-6749(22)00223-8/pdf
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751